Phathom Pharmaceuticals

Phathom Pharmaceuticals

Edit info

  • Founded: 2019
  • Location: Menlo Park, CA
  • Employee range: 50 - 200
  • Clinical stage: COM
  • Therapy area: H. pylori infection
  • Drug types: INF, GI, PED
  • Lead product: Voquezna (Vonoprazan) 
  • Funding: $150M stock May 2023; $182M IPO Oct 2019; $90M May 2019
  • Investors: Frazier Healthcare Partners, Medicxi, RA Capital Management, Abingworth


phathompharma.com

linkedin.com

job board


Business:

Novel treatments for gastrointestinal diseases and disorders

Drug notes:

Also NDA errosive GERD, heartburn, Clin3 heartburn in non-erosive GERD, different dosing Clin2 heartburn in non-erosive GERD, Clin2 eosinophilic esophagitis

About:

Phathom Pharmaceuticals is dedicated to improving treatments for gastrointestinal (GI) diseases. They focus on developing innovative therapies for acid-related disorders like ulcers and heartburn. One key area of their research is the development of new proton pump inhibitors – a class of drugs that reduce stomach acid production. While there are existing PPIs on the market, Phathom is investigating more effective and potentially longer-lasting options. This could lead to improved patient outcomes and potentially reduce the need for frequent medication use.

Phathom Pharmaceuticals
Director Patient Marketing Analytics
Florham Park, NJ|32 days ago
Apply
Phathom Pharmaceuticals
Corporate and Securities Counsel
Florham Park, NJ|49 days ago
Phathom Pharmaceuticals
Territory Sales Representative
Raleigh, NC|67 days ago
Phathom Pharmaceuticals
Territory Sales Representative
Midland, MI|73 days ago
Phathom Pharmaceuticals
Regional Sales Manager - Philadelphia PA
United States|93 days ago
Phathom Pharmaceuticals
Manager Market Access Operations
Florham Park, NJ|100+ days ago
Phathom Pharmaceuticals
Territory Sales Representative
Troy, MI|Not provided


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com